HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cheryl Wannstedt Selected Research

Hepatitis

5/2005Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Cheryl Wannstedt Research Topics

Disease

6Infections
11/2008 - 01/2004
2Mycoses (Diseases, Fungus)
02/2008 - 05/2005
2Bacteremia
12/2007 - 05/2005
2Cytomegalovirus Infections (Inclusion Disease)
06/2005 - 01/2004
2Opportunistic Infections (Opportunistic Infection)
05/2005 - 01/2005
1Viremia
02/2008
1Hepatocellular Carcinoma (Hepatoma)
12/2007
1Liver Diseases (Liver Disease)
12/2007
1Iron Overload
12/2007
1Staphylococcal Infections
02/2006
1Hepatitis
05/2005
1Bacterial Infections (Bacterial Infection)
05/2005
1Superinfection
05/2005

Drug/Important Bio-Agent (IBA)

2ValganciclovirFDA Link
02/2008 - 01/2005
2Antiviral Agents (Antivirals)IBA
06/2005 - 05/2005
1CytokinesIBA
11/2008
1IronIBA
12/2007
1Ganciclovir (Cytovene)FDA LinkGeneric
01/2005

Therapy/Procedure

6Liver Transplantation
11/2008 - 01/2004
3Therapeutics
02/2008 - 05/2005
2Transplantation
12/2007 - 02/2006